-
irritable bowel syndrome
- motility disorder of lower GI tract
- chronic disorder
- patho: no identifiable cause, CNS regulation of bowel is altered
- dx: 3 days per month past 3 mos of 2/3 sx
-
IBS manifestations
- 1 - abd pain relieved by defecation (spasms or dull/continuous)
- 2 - change in frequency
- 3 - change in form
- **mucus**
- bloating/gas
- N&V
- anorexia
- fatigue
- HA
- dep/anx
- tender abd (sigmoid)
-
IBS dx
- r/o other causes
- stool for RBCs, WBCs, ova, parasites
- sigmoidoscopy
- colonoscopy
- small bowel series (upper GI w/small bowel follow through)
- CBC/ESR
-
IBS meds
- goal: manage symptoms
- bulk forming laxatives
- anticholinergics
- antidepressants
- antidiarrheals
- herbs/probiotics
-
bulk forming laxatives
- reduce spasms, promote regularity
- encourage H20
- bran
- methylcellulose
- psyllium
-
anticholinergics
- inhibit bowel motility by interfering with PNS stimulation
- relieves abd pain/cramping
- 30-60 min before meals
- s/e: dry mouth, blurred vision, urinary hesitancy
- monitor bowel sounds, flatus
- dicyclomine (Bentyl), hyoscyamine (Anaspaz)
-
antidepressants
- tricyclics/SSRIs
- relieve abd pain/DHR r/t anticholinergic s/e
-
antidiarrheals
loperamide (Imodium), diphenoxylate (Lomotil)
-
IBS nutrition
- increased fiber
- limit sugars
- limit gas forming foods (beans, broccoli, beans, cabbage, nuts, raisins)
- limit caffeine (GI stimulant)
-
inflammatory bowel disease
- IBD = ulcerative colitis and Crohn's disease
- closely related
- unknown etiology
- risk factors: genetics, autoimmune, smoking, contraceptives
- UC - large bowel in continuous pattern (distal to proximal)
- CD - small intestine, patchy pattern
-
ulcerative colitis
- chronic inflammatory bowel disorder
- affects mucosa/submucosa of colon and rectum in a continuous pattern
- mild to moderate ( <6 stools daily)
- distal rectosigmoid colon > progresses proximally > fulminant colitis (entire colon)
- microscopic hemorrhages > crypt abscesses that spread laterally
- mucosa red/edematous/ulcerated > hemorrhage and necrosis
-
UC manifestations
- DHR with blood and mucus
- --mild: <4/day
- --severe: up to 20/day
- anemia
- hypovolemia
- malnutrition
- fecal urgency
- LLQ cramping
- fatigue
- anorexia
- weakness
-
UC complications
- hemorrhage
- toxic megacolon - colon dilates
- colon perforation > peritonitis
- increased r/f colon cancer
-
Crohn's disease
- chronic inflammatory GI disorder
- can affect mouth to anus
- usually affects terminal ileum/ascending colon
- small patchy lesions of mucosa and submucosa > ulcerations and fistulas
-
Crohn's manifestations
- DHR - liquid or semiformed (no blood)
- abd pain/tenderness - RLQ
- abscesses
- malnutrition
- fever
- malaise
- fatigue
- weight loss
- anemia
- fissures
- ulcers
-
Crohn's complications
- scarring
- strictures
- adhesions
- fistula > abscess, chills, fever, abd mass, leukocytosis, DHR, WL, malnutrition
- obstruction r/t repeated inflammation, scarring
- perforation > peritonitis
-
IBD dx
- sigmoidoscopy
- colonoscopy
- barium upper/lower GI
- stool for WBCs, RBCs, ova, parasites, bacteria, mucus (r/o other causes)
- CBC
- --anemia r/t chronic inflammation, blood loss, malnutrition
- --leukocytosis r/t inflammation, abscesses
- ESR, C-reactive r/t inflammation
- serum albumin decreased r/t malabsorption, malnutrition, protein loss
- folic acid/vitamin levels decreased r/t malabsorption, malnutrition
- LFTs - inflamed duodenum > bile backs up into liver
-
IBD meds
- goal: remission
- anti-inflammatories
- corticosteroids
- immunosuppressants
- antibiotics
-
sulfasalazine (Azulfidine)
- sulfonamide antibiotic/anti-inflammatory
- poorly absorbed, acts topically to inhibit inflammatory process
- s/e: HA, N&V, rash
-
olsalazine (Dipentum)/mesalamine (Asacol Rowasa)
- non-sulfa form of sulfasalazine
- fewer side effects
- rectal or oral
-
corticosteroids
- reduce inflammation, induce remission for acute exacerbations
- hydrocortisone rectally for topical relief
- IV for severe
- PO for mild to moderate
-
immunosuppressants
- for pt not responding to other therapy
- maintain remission, facilitate healing
- azathioprine (Imuran)
- methotrexate
- cyclosporine (Sandimmune)
-
monoclonal antibody
- infliximab (Remicade)
- suppresses tumor necrotic factor (inflammatory mediator)
-
antibiotic
- metronidazole (Flagyl)
- antibiotic with anti-inflammatory effects
-
IBD diet
- eliminate triggers (milk, gluten)
- NPO during exacerbation
- low residue diet
- TPN
- elemental (Ensure)
-
IBD surgery
- bowel obstruction
- perforation
- fistula
- abscess
- perianal complications
-
colectomy
- surgical resection and removal of colon
- extensive UC
- IPPA - ileal pouch anal anastomosis - pouch attached to rectum
-
liver functions
- produces albumin - primary plasma protein
- produces cholesterol
- metabolizes carbs, fats, proteins > ammonia > urea > kidney > urine
- metabolizes ETOH, drugs
- stores vitamins ADEK
- stores glycogen
- stores iron (ferritin)
- unconjugated bilirubin > direct bilirubin > bile > GB
- metabolizes aldosterone > aldactone
- stores blood
- synthesizes clotting factors (all except von W)
- produces and secretes bile > break down fats
- breaks down bacteria (Kupffer cells)
-
hepatitis
- inflammation of the liver
- damages hepatic cells, disrupts liver function
- impaired bile flow > jaundice
- patho: hep virus replicates in liver > damages hepatocytes > immune response > inflammation/necrosis
-
hepatitis variations
- A - fecal/oral, abrupt, benign/self-limiting
- B - blood/body, slow onset, vaccine
- C - blood/body, slow onset
- D - blood/body, abrupt, must have B to get it, B vaccine protects against it
- E - fecal/oral, abrupt
- B+D - fulminant hepatitis - fatal in 2 weeks if untreated
-
prodromal/preicteric phase
- flu-like symptoms
- GI upset
- muscle aches
- polyarthritis
- RUQ pain
- tenderness
-
icteric phase
- jaundice r/t hyperbilirubinemia s/t inflammation of liver and bile ducts
- pruritus r/t bile salts on skin
- clay-colored stools r/t lack of bile pigment in stool
- brown urine r/t excess bile excreted in urine
- no fever
- increased appetite
-
convalescent/post-icteric phase
- normalization of enzyme, bilirubin levels
- increased energy
- decreased pain
-
hepatitis dx
- LFTs
- ALT - enzyme contained in liver cells - released when damaged
- AST - enzyme in heart and liver cells - released when damaged
- ALP - enzyme in liver and bone cells
- GGT - enzyme increase with ETOH use
- LDH
- bilirubin - elevated r/t impaired bilirubin metabolism/biliary duct obstruction
- viral antigen - HAV, HBV, HCV, HDV
- liver biopsy - lay on R side 2 hours post, monitor for bleeding
-
hepatitis meds - prevention
- vaccines: Hep A, Hep B/D
- post-exposure prophylaxis: immune globulin (IG)
-
hepatitis meds - treatment
- mild/moderate - not treated
- severe acute B - antiretroviral - lamivudine (Epivir)
- --decreases liver inflammation and fibrosis
- acute C - antiviral - interferon alpha - reduces risk of chronic C
- --also used for chronic B and C
- --s/e: flu-like symptoms, depression
- chronic C - combo antiviral - peginterferon (Pegasys) and ribavirin (Rebetol)
- --s/e: hemolytic anemia
- milk thistle, licorice root (increased r/f HTN)
-
hepatitis nursing
- acute: bedrest
- prevention
- food safety
- safe sex
- vaccination
- prophylactic treatment
- infection control
- rest periods
- nutrition
- avoid hepatotoxins (mushrooms, Tylenol)
-
hepatitis diet
- high carb diet
- avoid ETOH, diet drinks
- nutritional supplements
-
hepatitis nursing dx
- risk for infection (transmission)
- fatigue r/t s/e of hepatitis
- imbalanced nutrition - less than body requirements r/t immune function
- disturbed body image r/t jaundice, rash
-
cirrhosis
- fibrosis of liver tissue > decreased mass, impaired liver function, altered blood flow
- caused by ETOH, prolonged biliary obstruction, chronic Hep B/C, severe R HF (liver congestion)
- patho: liver tissue replaced by fibrous tissue > hepatocytes destroyed > liver function declines > disrupted blood flow to IVC > portal HTN
-
types of cirrhosis
Laennec's - from ETOH use - increased triglyceride, fatty acid synthesis, decreased formation and release of lipoproteins > fatty liver > inflammation > necrosis, fibrosis
-
posthepatic - chronic Hep B/C > immune response > liver damage (shrunken, nodular)
biliary - obstructed bile flow > retained bile in liver causes damage, destroys liver cells> inflammation > liver damage
-
cirrhosis manifestations
- early
- --few s/s
- --enlarged, tender liver
- --dull epigastric or RUQ pain
- --WL, anorexia
- --weakness
- late
- --impaired metabolism > bleeding, ascites, gynecomastia, infertility, jaundice, neuro changes
- --portal HTN > edema, anemia, low WBC/platelet
-
portal HTN
- increased pressure in portal system causes blood to be rerouted to adjoining vessels
- congested veins in esophagus, rectum, abdomen
- increased hydrostatic pressure causes fluid to shift into abd cavity > ascites
-
ascites
- accumulation of plasma-rich fluid in abd cavity
- caused by portal HTN
- hypoalbuminemia decreases osmotic pressure of plasma > fluid escapes into extravascular space
- hyperaldosteronism increases Na and H20 retention > contributes to ascites
- s/s: caput medusa
-
esophageal varices
- enlarged veins in esophagus caused by portal HTN (blood backs up into esophageal veins)
- can rupture > massive hemorrhage
- contributing factors: thrombocytopenia, decreased clotting factors
- tx: beta blocker to decrease portal HTN, triple lumen NG (Blakemore/Minnesota) to tamponade vessels (monitor airway)
-
splenomegaly
- enlarged spleen caused by portal HTN (causes blood back up into splenic vein)
- increases rate of blood cell destruction > anemia, leukopenia, thrombocytopenia
-
hepatic encephalopathy
- accumulation of neurotoxins (ammonia) in blood, cerebral edema
- liver cannot convert ammonia to urea (lactulose to excrete ammonia, destroy bacteria)
- s/s: asterixis, agitation, restlessness, impaired judgement, slurred speech, confusion, disorientation
-
asterixis
- aka liver flap
- early sign of hepatic encephalopathy
- extend arms, dorsiflex wrist - hands would flap down
-
hepatorenal syndrome
- rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure
- caused by altered blood flow to kidneys s/t liver failure, portal HTN
- precipitated by GI bleed, diuretics
-
spontaneous bacterial peritonitis
- inflammation of peritoneum
- inflammatory response worsens ascites (increased capillary permeability)
- s/s: increased abd discomfort, pain, fever, increased ascites, worsening encephalopathy
-
cirrhosis dx
- LFTs - elevated but not as severe as acute hep
- CBC - low r/t splenomegaly, anemia
- Coag studies - prolonged PT r/t decreased clotting factors, lack of vitamin K (stored in liver)
- electrolytes - hyponatremia (hemodilution), hypokalemia, hypophosphatemia, hypomagnesemia (malnutrition, altered renal function)
-
bilirubin - elevated direct and indirect
- albumin - low r/t impaired production
- ammonia - elevated r/t inability to convert to urea for renal excretion
- glucose - abnormal (high or low)
- abd u/s - liver size, nodules, ascites
- esophagoscopy - varices
- liver biopsy
-
cirrhosis meds
- goal: treat complications
- avoid ETOH, hepatotoxic drugs
- diuretics
- laxatives
- anti-biotics
- beta blocker
- antacids
- iron/folic acid/Vitamin K
- oxazepam
- octreotide
-
diuretics
- spironolactone (Aldactone) - reduces ascites by decreasing aldosterone levels
- furosemide (Lasix) - excrete potassium
-
laxatives
- lactulose (Cephulac)
- reduces ammonia-producing bacteria in colon and converts ammonia to ammonium ion > excreted
-
antibiotics
- neomycin (Neo Tabs)
- decrease ammonia production in bowel
- ototoxic/nephrotoxic
-
beta blocker
- nadolol (Corgard), propanolol (Inderal)
- reduce portal HTN, prevent esophageal bleed
-
antianxiety
- oxazepam (Serax)
- not metabolized by liver
-
octreotide
- vasoconstricts portal vessels
- esophageal varices
-
cirrhosis diet
- restrict sodium/fluids
- adequate protein
- ADEKs
- iron
-
paracentesis
- dx or tx (relieve resp distress)
- can remove large vol of fluid - IV albumin given to maintain fluid volume
- patient voids prior, sits upright to avoid bowl perf
-
TIPS
- transjugular intrahepatic portosystemic shunt
- emergent relief of portal HTN
- allows blood flow from portal vein to hepatic vein (bypass liver)
- short term fix until liver transplant
-
liver transplant
- criteria: irreversible cirrhosis, decline in function, increasing bilirubin, decreasing albumin
- contraindications: malignancy, active ETOH/drug abuse, poor surgical risk
- immunosuppressives or life
- whole liver or individual lobes
-
cirrhosis nursing dx
- excess fluid volume r/t portal HTN, hypoalbuminemia, hyperaldosteronism
- disturbed thought process r/t encephalopathy
- ineffective protection r/t impaired coagulation
- impaired skin integrity r/t jaundice (pruritus)
- imbalanced nutrition - less than body requirements r/t malnutrition (ETOH, anorexia, impaired vitamin absorption, impaired protein metabolism)
|
|